Articles & Research

Editorial guides, provider comparisons, and treatment insights to help you research care options.

Showing posts in Medication Insights. Evidence-based analysis of medications and dosing protocols

Retatrutide Will Send a Shockwave Through the GLP-1 World

Phase 2 data show roughly 24% mean weight loss at 48 weeks with retatrutide. With Phase 3 and an outcomes trial underway, here is how a triple agonist could reset the GLP-1 era.

D, DOct 20, 20258 min read